Novel Bio

Startup

Novel Bio is a lean, technology-differentiated CDMO providing a secure, domestic alternative for your critical raw materials. By combining optimized traditional E. coli platforms with agile operations, we deliver R&D, High-Quality (HQ), and GMP-grade plasmid DNA to help you meet your clinical milestones with fiscal and regulatory certainty at 50% or more the costs of other providers. We aim to overcome the DNA bottleneck and help bring a new generation of medicine to patients.



website

Get Involved At World Orphan Drug Congress USA

 

Connect with us

 
 
 

 

To Sponsor Or Exhibit

 
 

Jack Rendell
jack.rendell@terrapinn.com
t/ +44 07577689029

 

 

 

To Speak

 
 

Abdu Kauroo
abdu.kauroo@terrapinn.com
 

 

 

 

Marketing & Press

 
 

Jasper Cameron
jasper.cameron@terrapinn.com